Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

Federal Funding Should Be Available For Abortion Services, Opinion Piece Says
"The current debate over government funding for abortion in the health care plan is a reminder of how we have failed poor women," Frances Kissling writes in a Salon opinion piece. According to Kissling, the 32-year-old Hyde Amendment, which prohibits federal funding for abortion services, has played a large role in denying impoverished women access to the procedure. "Restoring those funds has not been a top priority for pro-choice advocates, who sadly concluded that because the public does not care about poor women and is actually hostile to poor women who have sex and become pregnant, it would be futile to put too much capital into reversing Hyde," Kissling writes.However, "we have an opportunity to make amends" by reversing the Hyde Amendment and restoring federal funding for abortion services, according to Kissling. "But the portents are not promising," she writes, adding that a group of "pro-life" Democrats in the House in a recent letter to House Speaker Nancy Pelosi (D-Calif.) "laid down the first major antiabortion challenge to health care reform." In addition, the Obama administration "has refused to rule out including abortion in the health care package, but President Obama is already signaling that the status quo on abortion is likely to endure," Kissling writes."The longer it takes to pass a plan, the more momentum against including coverage for abortion -- and possibly contraception -- will build," Kissling writes, adding that "there is a good chance there will be limits on government funding for abortions in the health care package, if not outright exclusion." A compromise being considered by the House Energy and Commerce Committee would not prohibit or require private insurers offering government plans from covering abortions but would prohibit the use of federal funds to pay for them. "Whether this would result in a reduction of coverage in such plans is unclear, but it is possible," she continues."The timing is critical. The need is great, and growing," Kissling writes, adding, "If abortion services are excluded from the health care reform package, the number of women who will not be able to afford abortions is bound to rise and the number of unwanted children will increase." Kissling concludes, "One hears over and over again that we all agree that the health care system is broken; the status quo is not acceptable. The status quo on coverage for abortion is especially unacceptable" (Kissling, Salon, 7/27).
buy viagra
Medical Defence Union Encourages Doctors To Say Sorry If Things Go Wrong, UK
The Medical Defence Union (MDU) the UK"s largest medical defence organisation has reassured doctors that they are not admitting liability if they apologise when something has gone wrong with their treatment of a patient.
News of the day
Tamiflu-Resistant H1N1 Identified Along Texas-Mexico Border
PAHO on Monday announced it had found Tamiflu-resistant H1N1 (swine) flu along the Texas-Mexico border, Agence-France Press reports. The discovery of several cases in El Paso and McAllen, Texas, adds the U.S. to a growing list of countries with antiviral-resistant H1N1, such as Canada, Denmark, Hong Kong and Japan. "Experts had gathered in La Jolla on Monday to discuss the response to the outbreak, and warned that resistant strains were likely emerging because of overuse of antivirals like Tamiflu," the news service writes (8/3).
Diagnostics

PinPointe™ FootLaser™ Submits Its Breakthrough Laser Treatment For Toenail Fungus To Health Canada For Approval

PinPointe FootLaser announced it has submitted its innovative new laser treatment for toenail fungus (Onychomycosis) to Health Canada for approval. As the Federal department responsible for helping Canadians maintain and improve their health, Health Canada reviews medical devices to assess their safety, effectiveness and quality before being authorized for sale in Canada. PinPointe FootLaser has been awarded the CE Mark certifying it has met European Union consumer health and safety standards, has been cleared for use in the treatment of toenail fungus in the EU, and can be offered by healthcare providers throughout Europe. Additionally, the treatment is FDA cleared for applications in dermatology, plastic surgery, and podiatry in the United States. John Strisower, CEO of PathoLase, noted that he is confident the device will be made available to licensed Canadian medical practitioners after the Health Canada review process is completed. Stated Strisower: "Onychomycosis afflicts approximately 900 million people around the world, including millions in Canada. We"re very much looking forward to making PinPointe FootLaser available to Canadian practitioners as well, offering them an excellent opportunity for providing a unique and valuable service to their patients." Safe Quick Treatment - No Drugs, Pain or Anesthesia Introduced in 2008, PinPointe FootLaser uses a patented laser technology to target the pathogens that cause toenail fungus. With PinPointe FootLaser, patients are treated safely and quickly with no drugs, no anesthesia and no pain. PinPointe"s laser light passes through the toenail without causing damage to the nail or surrounding skin. Following the procedure, the new nail will grow in healthy and clear. Unlike medication-driven treatments for toenail fungus, PinPointe FootLaser presents minimal risk of side effects. Competing medication procedures can result in a wide variety of side effects, including liver toxicity. New Clinical Trial Currently Underway Following an early study conducted among a small group of patients (Harris, McDowell and Strisower, Laser Treatment for Toenail Fungus, Proc. SPIE 7161A, 2009), which indicated a potential efficacy rate as high as 87%, the treatment is currently undergoing a major multi-site clinical trial entitled "Multi-Center Trial: Evaluation of PinPointe FootLaser Treatment for Infected Toenails (Onychomycosis)". The study, which has been granted approval by Health Canada, is being conducted at the dermatology clinic and research facility of Aditya K. Gupta, M.D., Ph.D., M.A. (Cantab), DABD, FAAD, FRCPC in London, Ontario, as well as at three additional sites in the U.S. About PinPointe FootLaser PinPointe™ FootLaser™ is a groundbreaking laser treatment for toenail fungus that was launched in September 2008 by Chico, CA-based PathoLase, Inc. PinPointe FootLaser targets the pathogens that cause toenail fungus (Onychomycosis), an infection that afflicts an estimated 40 million people in the U.S. alone. PinPointe FootLaser recently received the first and only medical device clearance for toenail fungus treatment in Europe (CE Mark). For more information please visit http://www.pinpointefootlaser.com. PathoLase, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009